Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume -, Issue -, Pages 1-21
Publisher
Informa UK Limited
Online
2019-05-28
DOI
10.1080/13543776.2019.1623880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity
- (2018) Shabnam Farzaneh et al. Anti-Cancer Agents in Medicinal Chemistry
- Synthesis, in vitro and in silico evaluation of novel trans -stilbene analogues as potential COX-2 inhibitors
- (2018) Miłosz Regulski et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition
- (2018) Shen-Zhen Ren et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of novel pyrazolo-oxothiazolidine derivatives as antiproliferative agents against human lung cancer cell line A549
- (2018) S. Yakaiah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Rational drug design and synthesis of new α-Santonin derivatives as potential COX-2 inhibitors
- (2018) Adriana Coricello et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis, anti-inflammatory antitumor activities, molecular modeling and molecular dynamics simulations of potential naprosyn® analogs as COX-1 and/or COX-2 inhibitors
- (2018) Mardia T. El Sayed et al. BIOORGANIC CHEMISTRY
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Focused library design and synthesis of 2-mercapto benzothiazole linked 1,2,4-oxadiazoles as COX-2/5-LOX inhibitors
- (2018) Satayanarayana Yatam et al. JOURNAL OF MOLECULAR STRUCTURE
- Design, synthesis and biological evaluation of new 1,3-diphenyl-3-(phenylamino)propan-1-ones as selective cyclooxygenase (COX-2) inhibitors
- (2018) Shabnam Farzaneh et al. Medicinal Chemistry
- Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
- (2018) Srishti Singh et al. MOLECULES
- Novel 1,4-benzothazines obliterate COX-2 mediated JAK-2/STAT-3 signals with potential regulation of oxidative and metabolic stress during colorectal cancer
- (2018) Amit Rai et al. PHARMACOLOGICAL RESEARCH
- Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis
- (2018) Ping Dai et al. OncoTargets and Therapy
- 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity
- (2018) Fatima Naaz et al. BIOORGANIC CHEMISTRY
- Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy
- (2018) Shen-Zhen Ren et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking
- (2018) Walaa M. El-Husseiny et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 1,2,3-Triazolyl ester of Ketorolac: A “Click Chemistry”-based highly potent PAK1-blocking cancer-killer
- (2017) Binh Cao Quan Nguyen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice
- (2017) Nobuharu Noma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors
- (2016) Md. Jashim Uddin et al. ACS Chemical Biology
- Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis
- (2016) Xiao-Yuan Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Stromal COX-2 signaling are correlated with colorectal cancer: A review
- (2016) Chen-Wei Su et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- COX-2 inhibitors: a novel strategy in the management of breast cancer
- (2016) Miłosz Regulski et al. DRUG DISCOVERY TODAY
- Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy
- (2016) Hao Cai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies
- (2016) Belgin Sever et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition
- (2016) Han-Yue Qiu et al. PHARMACOLOGICAL RESEARCH
- Mitochondrial toxicity of selective COX-2 inhibitors via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria
- (2016) Muzeeb Syed et al. TOXICOLOGY IN VITRO
- Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors
- (2015) Zhong Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ferrocifen type anti cancer drugs
- (2015) Gérard Jaouen et al. CHEMICAL SOCIETY REVIEWS
- Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer
- (2015) Celeste Monte et al. CURRENT MEDICINAL CHEMISTRY
- Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
- (2015) Rui Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- In Vitro and in Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment
- (2015) Massimo Fantini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrin traffic - the update
- (2015) N. De Franceschi et al. JOURNAL OF CELL SCIENCE
- Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors
- (2014) Kyung Ju Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity
- (2014) Shadia A. Galal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism
- (2014) Carmen B. Rödl et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives
- (2014) Mohammed I. El-Gamal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents
- (2014) Ahmed Temirak et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities
- (2013) Shibnath Ghatak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and biological activity of aminophthalazines and aminopyridazines as novel inhibitors of PGE2 production in cells
- (2012) Federico Medda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells
- (2012) YE-WON JEON et al. ONCOLOGY REPORTS
- Polycyclic aromatic compounds as anticancer agents: Evaluation of synthesis and in vitro cytotoxicity
- (2011) DEBASISH BANDYOPADHYAY et al. Oncology Letters
- Organometallic Anticancer Compounds
- (2010) Gilles Gasser et al. JOURNAL OF MEDICINAL CHEMISTRY
- PCNA on the crossroad of cancer
- (2009) Ivaylo Stoimenov et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
- (2008) M. Bernard et al. CURRENT PHARMACEUTICAL DESIGN
- Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited—old leads for new applications?
- (2008) Claudia Temperini et al. ORGANIC & BIOMOLECULAR CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started